deltatrials
Terminated NA INTERVENTIONAL 1-arm NCT02290028

Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads (QP ExCELs)

Sponsor: Biotronik SE & Co. KG

Conditions Heart Failure
Updated 24 times since 2017 Last updated: Mar 1, 2021 Started: Dec 16, 2014 Primary completion: Jan 23, 2020 Completion: Jan 23, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

BIOTRONIK received FDA approval to transition the ongoing Sentus QP Study to a new EP PASSION real-world data methodology.

Listed as NCT02290028, this NA trial focuses on Heart Failure and remains terminated or withdrawn. Sponsored by Biotronik SE & Co. KG, it has been updated 24 times since 2014, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshot~Mar 2017 – ~Apr 2017 · 31 days · monthly snapshot~Apr 2017 – ~May 2017 · 30 days · monthly snapshot~May 2017 – ~Jul 2017 · 2 months · monthly snapshot~Jul 2017 – ~Oct 2017 · 3 months · monthly snapshot~Oct 2017 – ~Dec 2017 · 2 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Oct 2018 · 3 months · monthly snapshot~Oct 2018 – ~Jan 2019 · 3 months · monthly snapshot~Jan 2019 – ~Mar 2019 · 59 days · monthly snapshot~Mar 2019 – ~Oct 2019 · 7 months · monthly snapshot~Oct 2019 – ~Dec 2019 · 2 months · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Nov 2020 · 9 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Dec 2021 · 8 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

24 versions recorded
  1. Sep 2025 — Present [monthly]

    Terminated NA

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated NA

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  4. Dec 2021 — Jul 2024 [monthly]

    Terminated NA

  5. Apr 2021 — Dec 2021 [monthly]

    Terminated NA

Show 19 earlier versions
  1. Jan 2021 — Apr 2021 [monthly]

    Terminated NA

  2. Nov 2020 — Jan 2021 [monthly]

    Terminated NA

  3. Feb 2020 — Nov 2020 [monthly]

    Terminated NA

    Status: RecruitingTerminated

  4. Jan 2020 — Feb 2020 [monthly]

    Recruiting NA

  5. Dec 2019 — Jan 2020 [monthly]

    Recruiting NA

  6. Oct 2019 — Dec 2019 [monthly]

    Recruiting NA

  7. Mar 2019 — Oct 2019 [monthly]

    Recruiting NA

  8. Jan 2019 — Mar 2019 [monthly]

    Recruiting NA

  9. Oct 2018 — Jan 2019 [monthly]

    Recruiting NA

  10. Jul 2018 — Oct 2018 [monthly]

    Recruiting NA

  11. Jun 2018 — Jul 2018 [monthly]

    Recruiting NA

  12. Dec 2017 — Jun 2018 [monthly]

    Recruiting NA

  13. Oct 2017 — Dec 2017 [monthly]

    Recruiting NA

  14. Jul 2017 — Oct 2017 [monthly]

    Recruiting NA

  15. May 2017 — Jul 2017 [monthly]

    Recruiting NA

  16. Apr 2017 — May 2017 [monthly]

    Recruiting NA

  17. Mar 2017 — Apr 2017 [monthly]

    Recruiting NA

  18. Feb 2017 — Mar 2017 [monthly]

    Recruiting NA

  19. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Dec 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Biotronik SE & Co. KG
  • Biotronik, Inc.
Data source: Biotronik SE & Co. KG

For direct contact, visit the study record on ClinicalTrials.gov .